SPECIAL FEATURE – Patients & Physicians Desire Transdermal, Topical & Subcutaneous Delivery

7/21/14

Drug Development & Delivery Magazine
July 2014

As adhesives are a key component of transdermal systems, patch manufacturers are taking a more judicious approach in adhesive selection to assure compliance with FDA guidelines for safety (skin irritation and sensitization) and minimizing residual drug content. Adhesives Research offers customized services to formulate and manufacture both bulk adhesives and adhesive laminates for transdermal applications and sister company, ARx, LLC, takes this a step further in the creation of drug-loaded adhesives and films for specific APIs.  Read more.